» Articles » PMID: 38895658

Magnesium Status Modulating the Effect of Serum Vitamin D Levels on Retinopathy: National Health and Nutrition Examination Survey 2005 to 2008

Overview
Journal Front Nutr
Date 2024 Jun 19
PMID 38895658
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Magnesium levels may influence the effect of vitamin D levels on the body. This study aimed to assess the combined effect of magnesium status as reflected by magnesium depletion score (MDS) and vitamin D status on the risk of retinopathy.

Methods: This cross-sectional study included participants aged 40 years and older with complete information on vitamin D, MDS, and retinopathy assessment from the 2005-2008 National Health and Nutrition Examination Survey (NHANES). Logistic regression analysis was utilized to analyze the relationship of MDS and vitamin D with retinopathy and expressed as odds ratio (OR) and 95% confidence interval (CI).

Results: Of these 4,953 participants included, 602 (9.53%) participants had retinopathy. Serum vitamin D levels ≤30 nmol/L (vs. >30 nmol/L) (OR = 1.38, 95%CI: 1.05-1.81) and MDS >2 points (vs. ≤2 points) (OR = 1.47, 95%CI: 1.01-2.16) were associated with higher odds of retinopathy. There was an interaction between MDS and vitamin D on the increased odds of retinopathy (OR = 2.29, 95%CI: 1.12-4.68,  = 0.025). In different MDS groups, serum vitamin D levels ≤30 nmol/L increased the odds of retinopathy only in the MDS >2 group (OR = 2.90, 95%CI: 1.16-7.24), but not in the MDS ≤2 group ( = 0.293). Subgroups analyses demonstrated that the interaction between MDS and serum vitamin D on retinopathy was observed in males (OR = 6.88, 95%CI: 1.41-33.66,  = 0.019), people with diabetes (OR = 3.43, 95%CI: 1.78-6.63,  < 0.001), and people with body mass index (BMI) ≥25 kg/m (OR = 2.46, 95%CI: 1.11-5.44,  = 0.028).

Conclusion: Magnesium plays a moderating role in the relationship between serum vitamin D and retinopathy. The protective effect of vitamin D against retinopathy was primarily present among those with inadequate magnesium levels.

References
1.
Menke A, Casagrande S, Geiss L, Cowie C . Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. JAMA. 2015; 314(10):1021-9. DOI: 10.1001/jama.2015.10029. View

2.
Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Kostenberger M, Tmava Berisha A . Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020; 74(11):1498-1513. PMC: 7091696. DOI: 10.1038/s41430-020-0558-y. View

3.
Zmijewski M . Vitamin D and Human Health. Int J Mol Sci. 2019; 20(1). PMC: 6337085. DOI: 10.3390/ijms20010145. View

4.
Elin R . Assessment of magnesium status for diagnosis and therapy. Magnes Res. 2010; 23(4):S194-8. DOI: 10.1684/mrh.2010.0213. View

5.
Szymczak-Pajor I, Drzewoski J, Sliwinska A . The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders. Int J Mol Sci. 2020; 21(18). PMC: 7554927. DOI: 10.3390/ijms21186644. View